CARR vs LAB · P/E 43, rev $5.15B vs rev $174.4M
Carrier Global Corp (CARR) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CARR and LAB stock pages for the full models.
Not investment advice.